SCHEMBL4621774

SCHEMBL4621774

NC1=Cc2cc(N)ccc2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.41
LMNA P02545 3/20 0.41
ALDH1A1 P00352 3/20 0.41
RAB9A P51151 2/20 0.41
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
TLR9 Q9NR96 1/20 0.34
CA9 Q16790 2/20 0.33
GAA P10253 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CASP1 P29466 3/20 0.32
HSD17B10 Q99714 2/20 0.32
CASP7 P55210 1/20 0.32
CYP3A4 P08684 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15961771 0.80 MAPT (0.40) MAPTLMNAALDH1A1RAB9AKDM4E
SCHEMBL10601676 0.78 MAPT (0.42) MAPTLMNAALDH1A1RAB9AKDM4E
SCHEMBL28629984 0.78 MAPT (0.38) MAPTLMNAALDH1A1RAB9AKDM4E
Bromide SCHEMBL27390508 0.77 ESR2 (0.36) CA9CA12CA1CA2
SCHEMBL29113469 0.74 ALDH1A1 (0.39) MAPTLMNAALDH1A1RAB9AKDM4E
SCHEMBL28666103 0.74 CYP11B2 (0.49) MAPTALDH1A1KDM4ESMN1; SMN2MEN1
SCHEMBL28662569 0.74 MAOA (0.41) MAPTLMNAALDH1A1KDM4ENPC1
SCHEMBL626635 0.73 MAOA (0.44) MAPTLMNAALDH1A1RAB9AKDM4E
SCHEMBL15170872 0.72 MAPT (0.36) MAPTLMNAALDH1A1RAB9AKDM4E
Hydrochloric Acid SCHEMBL4604224 0.71 MAOA (0.42) TSHRPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109810111-A A kind of pyrazolone miazines compound, preparation method and application 上海医药集团股份有限公司 2019-05-28 CN disclosed
EP-1883632-A1 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS Amgen Inc. (US) 2008-02-06 EP disclosed
EP-1828185-A2 2-PYRIMIDINYL PYRAZOLOPYRIDINE ERBB KINASE INHIBITORS SmithKline Beecham Corporation (US) 2007-09-05 EP disclosed
WO-2006116563-A1 VANILLOID RECEPTOR LIGANDS AND THEIR USE IN TREATMENTS AMGEN INC. (US) 2006-11-02 WO disclosed
WO-2006068826-A2 2-PYRIMIDINYL PYRAZOLOPYRIDINE ERBB KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2006-06-29 WO disclosed